First-time Fathers' Experiences of Childbirth in Lorraine (PRIMIPERE)

February 14, 2023 updated by: AVERCENC Léonore, Central Hospital, Nancy, France

First-time Fathers' Experiences of Childbirth in Lorraine.

The primary aim of this study is to evaluate first time father's experience during childbirth in three different maternity hospitals in Lorraine.

Secondary aims of this study is to identify domains that need improvement in order to enhance fathers's experience during childbirth.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Meurthe-et-Moselle
      • Nancy, Meurthe-et-Moselle, France, 54000
        • Maternité du CHRU de Nancy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Father for the first time.

Description

Inclusion Criteria:

  • First time father after a physiological pregnancy and delivery of a healthy newborn of more than 37 gestational weeks.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Type I maternity
Fathers who experienced a first childbirth in a type I maternity in Lorraine.
Other: First time father questionnaire self-administration
The first-time father questionnaire will be self-administrated to subjects 1 month post-birth.
Type II maternity
Fathers who experienced a first childbirth in a type II maternity in Lorraine.
Other: First time father questionnaire self-administration
The first-time father questionnaire will be self-administrated to subjects 1 month post-birth.
Type III maternity
Fathers who experienced a first childbirth in a type III maternity in Lorraine.
Other: First time father questionnaire self-administration
The first-time father questionnaire will be self-administrated to subjects 1 month post-birth.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First-time father questionnaire score
Time Frame: 1 month after birth
Minimum value of the scale = 1, maximum value = 4, higher score represent a bad experience for the father.
1 month after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Central Hospital, Nancy, France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 12, 2020

Primary Completion (Actual)

April 15, 2021

Study Completion (Actual)

September 19, 2022

Study Registration Dates

First Submitted

October 12, 2020

First Submitted That Met QC Criteria

October 12, 2020

First Posted (Actual)

October 19, 2020

Study Record Updates

Last Update Posted (Actual)

February 15, 2023

Last Update Submitted That Met QC Criteria

February 14, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2020PI138

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on First Birth

Clinical Trials on First time father questionnaire self-administration

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe